ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arkansas » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Arkansas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID EVANS M. D.

Cardiovascular Disease

22,872

$981K

1245
957 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $47

PAULO RIBEIRO MD

Cardiovascular Disease

18,215

$433K

1476
1157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 23%

$24
Average prescription price

Avg: $47

D HENRY MD

Cardiovascular Disease

13,836

$558K

1113
878 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $47

DAVID MEGO MD

Cardiovascular Disease

12,521

$661K

1090
857 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $47

JULIO SCHWARZ MD

Cardiovascular Disease

12,039

$1.08M

866
647 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 23%

$90
Average prescription price

Avg: $47

CHARLES CLOGSTON M.D.

Cardiovascular Disease

10,126

$395K

466
388 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $47

SCOTT BEAU MD

Cardiovascular Disease

9,574

$624K

977
759 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $47

WILLIAM BAILEY M.D.

Cardiovascular Disease

9,013

$475K

662
495 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $47

THOMAS CONLEY MD

Cardiovascular Disease

8,657

$466K

629
509 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $47

STEPHEN MANUS MD

Cardiovascular Disease

8,616

$381K

508
430 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $47

SADEEM MAHMOOD M.D.

Cardiovascular Disease

8,588

$391K

495
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $47

MICHAEL ISAACSON M.D.

Cardiovascular Disease

8,511

$423K

591
499 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $47

JOE HARGROVE M.D.

Cardiovascular Disease

8,291

$432K

731
490 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $47

ERICK ARANEDA M.D.

Cardiovascular Disease

7,999

$323K

694
580 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $47

GARY COLLINS MD

Cardiovascular Disease

7,726

$482K

697
600 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $47

MARK ST.PIERRE MD

Cardiovascular Disease

7,717

$319K

687
554 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $47

DAVID HICKS M.D.

Cardiovascular Disease

7,615

$314K

581
509 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $47

CARL LEDING MD

Cardiovascular Disease

7,567

$407K

658
505 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $47

TENA MURPHY MD

Cardiovascular Disease

7,264

$290K

529
467 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $47

WILSON WONG MD

Cardiovascular Disease

7,213

$354K

596
464 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $47

AMR EL-SHAFEI MD

Cardiovascular Disease

6,928

$335K

650
555 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $47

JAMES THOMAS M.D.

Cardiovascular Disease

6,871

$346K

656
469 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $47

JOHN HENDERSON MD

Cardiovascular Disease

6,839

$277K

596
526 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $47

JAMES HOLLOWAY MD

Cardiovascular Disease

6,807

$325K

524
461 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $47

EUMAR TAGUPA M.D.

Cardiovascular Disease

6,640

$258K

463
375 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $47

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank